Ekso Bionics Holdings, Inc.
EKSO
$3.49
$0.010.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -39.05% | -33.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -39.05% | -33.69% | |||
| Cost of Revenue | -21.10% | -33.96% | |||
| Gross Profit | -54.65% | -33.46% | |||
| SG&A Expenses | -3.33% | -12.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.09% | -9.36% | |||
| Operating Income | -21.93% | -46.19% | |||
| Income Before Tax | 6.30% | 15.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.30% | 15.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.30% | 15.29% | |||
| EBIT | -21.93% | -46.19% | |||
| EBITDA | -24.84% | -57.31% | |||
| EPS Basic | 27.23% | 17.80% | |||
| Normalized Basic EPS | 22.40% | 22.92% | |||
| EPS Diluted | 27.23% | 17.80% | |||
| Normalized Diluted EPS | 22.40% | 22.92% | |||
| Average Basic Shares Outstanding | 28.77% | 3.06% | |||
| Average Diluted Shares Outstanding | 28.77% | 3.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||